Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
This study has been terminated.
( Withdrawn because treatment guidelines changed )
Study NCT00005987
Information provided by National Cancer Institute (NCI)
First Received: July 5, 2000
Last Updated: September 1, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
